Zydus Lifesciences Limited (BOM:532321)
India · Delayed Price · Currency is INR 1,120.00
+11.20 (1.01%)
At close: Aug 21, 2026
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 1.12 trillion as of August 21, 2026. Its market cap has increased by 12.91% in one year.
Market Cap
1.12T
Enterprise Value
1.22T
Revenue
285.92B
Ranking
n/a
PE Ratio
24.76
Stock Price
1,120.00
ChartMarket Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 1.12T, an increase of 13,531.45%. That is a compound annual growth rate of 22.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 1.12T | 21.43% |
| Dec 31, 2025 | 920.05B | -5.90% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.91T |
| Lupin | 1.02T |
| Dr. Reddy's Laboratories | 975.42B |
| Abbott India | 560.98B |
| GlaxoSmithKline Pharmaceuticals | 513.99B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 297.76B |
| Granules India | 207.68B |